Exagen Market Cap

Exagen has a market cap or net worth of $69.14 million as of January 2, 2025. Its market cap has increased by 161.68% in one year.

Market Cap

69.14M

Enterprise Value

74.02M

1-Year Change

161.68%

Ranking

#4298

Market Cap Chart

Since September 19, 2019, Exagen's market cap has increased from $63.11M to $69.14M, an increase of 9.56%. That is a compound annual growth rate of 1.74%.

Market Cap History

Date	Market Cap	% Change
Dec 31, 2024	72.31M	113.18%
Dec 29, 2023	33.92M	-13.39%
Dec 30, 2022	39.17M	-79.17%
Dec 31, 2021	187.99M	12.56%
Dec 31, 2020	167.01M	-47.65%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	695.13B
UnitedHealth Group	465.54B
Novo Nordisk	384.34B
Johnson & Johnson	348.19B
AbbVie	314.02B
Merck & Co.	251.65B
AstraZeneca	203.17B
Thermo Fisher Scientific	198.99B

Market Cap Rankings